You have access
Current Status of Conversion Hepatectomy After Sorafenib and Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma
SHOHEI KOMATSU, YOSHIHIKO YANO, TAKUYA MIMURA, AKIHIRO MINAMI, KENJI MOMOSE, HIROTAKA HIRANO, MOTOFUMI TANAKA, YUKI UEDA, KENTARO TAI, YUKI YASUHARA, DAISUKE NAKAGAWA, ATSUSHI YAMAMOTO, MASAHIRO KIDO, YOSHIHIDE UEDA, YUZO KODAMA and TAKUMI FUKUMOTO
Anticancer Research July 2024, 44 (7) 3097-3103; DOI: https://doi.org/10.21873/anticanres.17123
